
RBS sets out hard Brexit costs
RBS could scarcely have scrubbed up better in the final quarter of 2018
Share this:

RBS could scarcely have scrubbed up better in the final quarter of 2018, the last before Brexit.
Margin up, bad loans down
Its closely watched net interest margin, which gauges underlying profitability from interest received on loans and paid on deposits, recouped 2 basis points (bp) in the quarter after falling 8bp to 1.93% in Q3. Also belying concerns that consumer credit and demand are set to deteriorate, bad loans fell 19% to £398m. Furthermore, RBS chose not to top-up Brexit-linked provisions of £100m set aside in October.
Pay outs point higher
Having delivered a pleasant surprise with a special 7.5p pay out on top of 5.5p over the year, the group stressed it could increase dividends even further. With net profits more than doubled to £1.6bn, CEO Ross MacEwan’s pledge to do that whilst sticking to a 14% key capital ratio is convincing. The Tier 1 ratio edged down to 16.2% last year from 16.7% in the year before.
‘Downside’ risk for cost rise
Still, though the stock was aloft all session, McEwan’s redoubled warning on Brexit prevented ebullience. Adding to the group’s track record of starker cautions on Britain’s EU divorce than its rivals, MacEwan noted “a heightened level of uncertainty related to the ongoing Brexit negotiations”. The group also tied probable challenges in reducing costs further to Brexit for the first time, with risks seen “to the downside”. A cost-to-income ratio target of less than 50% by 2020, has now become a “long-term” one. The retreat is backed by certain weak seams like RBS’s annual net interest margin slipping 15bp to 1.98%, missing 2.1% expected.
Brexit vs. sunny outlook
As such, Ross MacEwan’s increasingly strident warnings make sense. The sunniness, or not, of the bank’s medium-term outlook hangs inordinately on Brexit. Unlike its larger rival Lloyds, RBS’s basic return on equity looks thin on a 12-month basis at 1.6%, whilst the ‘tangible’ view showed 4.8% at last year end. The 12% target by 2020 is already a significant challenge and would probably be impossible in a disorderly Brexit. MacEwan’s lucid dividend hike has helped extend RBS stock’s climb to about 14% so far this year as confidence in the increasingly well-run bank builds. It’s uncertain how much benefit of the doubt investors will credit the group if chances of a no-deal Brexit rise.
Latest market news
View more newsOpen an account in minutes
Experience award-winning platforms with fast and secure execution, and enjoy tight spreads from 0.5 pts on FX and 0.3 pts on indices.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.

GBP/USD, Dow Jones Forecast: Key Technical Scenarios to Watch
GBP/USD and the Dow Jones are approaching critical technical levels amid earning optimism, Fed rate hike expectations, US-Iran developments, and persistent geopolitical risks.

The U.S. Dollar Is Rising Again and Nasdaq Is Feeling It
Nasdaq, the U.S. Dollar Index and Federal Reserve expectations are driving market sentiment ahead of a pivotal FOMC meeting. Razan Hilal, StoneX Market Analyst, explains how rising expectations for a hawkish Federal Reserve, persistent U.S.-Iran tensions and key technical levels on the U.S. Dollar Index could influence currencies, equities and precious metals in the weeks ahead.

US Dollar and Nasdaq Forecast: Fed, Microsoft, Meta, and Iran Talks in Focus
The US Dollar Index (DXY) continues to hold above the 101.00 mark, reinforcing its bullish structure, while the Nasdaq remains capped below the 29,000 resistance and its June-July consolidation range, reflecting cautious risk appetite ahead of the Federal Reserve's policy decision and major earnings releases on Wednesday.
This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.
StoneX Financial Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the StoneX group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), StoneX Financial Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact StoneX Financial Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.
In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither StoneX Financial Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.
StoneX Financial Pte. Ltd. is not under any obligation to update this report.
Trading CFDs carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit www.forex.com/en-sg/terms-and-policies for the complete Risk Disclosure Statement.





